Search

Search Constraints

You searched for: Author/Creator Shiono, Ayako

Search Results

2. Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events. Issue 5 (11th March 2020)

3. Clinical impact of post‐progression survival on overall survival in patients receiving nivolumab monotherapy as a second‐line treatment for advanced non‐small cell lung cancer. Issue 8 (24th February 2021)

5. Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer. Issue 4 (12th March 2019)

7. Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile. Issue 1 (December 2017)

8. Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients. Issue 4 (27th February 2019)

9. Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa‐associated lymphoid tissue lymphoma: A case report. Issue 10 (28th July 2022)

10. Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival. Issue 19 (5th September 2022)